-
Androgen deprivation therapy promotes an inflammatory and obesity-like microenvironment in periprostatic fat
Study
EGAS00001003286
-
Heterogeneous Genomic Evolution and Immune Microenvironments in Metastatic Lung Cancer
Study
EGAS00001004228
-
Comprehensive investigation of genome architecture of gastric adenocarcinoma with whole-genome sequencing in the Chinese population.
Study
EGAS00001002404
-
DAC: British Columbia Cancer Agency (BCCA), PHSAs Technology Development Office, Data Access Committee
Dac
EGAC00001000122
-
Molecular analysis of circulating tumour cells identifies distinct profiles in chemosensitive and chemorefractory patients with small cell lung cancer
Study
EGAS00001001951
-
Similarity and diversity of the tumor microenvironment in multiple metastases: critical implications for overall and progression-free survival of high-grade serous ovarian cancer.
Study
EGAS00001002065
-
Tracing the origin of disseminated tumor cells in breast cancer using single-cell sequencing
Study
EGAS00001002102
-
GENOMIC INSTABILITY IN MISMATCH REPAIR DEFICIENT COLORECTAL CANCER
Study
EGAS00001002477
-
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition
Study
EGAS00001002115
-
Inter and intra - tumor heterogeneity in Colorectal Cancer
Study
EGAS00001002150
-
miR-200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers
Study
EGAS00001002184
-
Sequencing of pancreatic cancer primary tumors and metastases
Study
EGAS00001002186
-
This study explored and validated the clinical application of targeted NGS of circulating tumor DNA in identifying tumor-specific mutations and uncovering clinical actionable targets in a variety of solid tumors in large patient cohorts.
Study
EGAS00001002251
-
A Functional Network of Gastric-Cancer-Associated Splicing Events Controlled by Dysregulated Splicing Factors
Study
EGAS00001002256
-
HDAC inhibitors in synovial sarcoma cells
Study
EGAS00001002637
-
Most HCCs in Taiwan show the mutational signature of aristolochic acid
Study
EGAS00001002301